This product is a macrolide antibiotic produced by Streptomyces narbonensis var. Josamyceticus. Its antibacterial spectrum is similar to that of erythromycin. Its antibacterial effect on Staphylococcus and Streptococcus is slightly worse than that of erythromycin, but it still has antibacterial activity against induced resistant strains. Meningococci and Bordetella pertussis are sensitive to this product. It has good antibacterial effect on anaerobic bacteria such as Peptococcus, Peptostreptococcus, Propionibacterium and Eubacterium. Intracellular pathogens such as Mycoplasma, Chlamydia and Legionella are also sensitive to this product. This product does not induce Staphylococcus to macrolide resistance and is a non-inducible antibiotic.

Nonsteroidal anti-inflammatory drugs, which have anti-inflammatory, antipyretic and analgesic effects, are effective for inflammatory pain, and also have papaverine-like spasmolytic effects

Alendronate sodium is an aminobisphosphonate bone resorption inhibitor with a strong affinity for hydroxyapatite in bone. This product exerts its anti-bone resorption effect by inhibiting the activity of osteoclasts. It is characterized by strong anti-bone resorption activity and no bone mineralization inhibition effect.

Unspecified

It is an H2 receptor blocker that can inhibit basal gastric acid and gastrin-stimulated gastric acid secretion, and reduce the activity of gastric acid and pepsin.

In the acidic environment of the stomach, it forms a diffuse protective layer covering the mucosal surface, preventing gastric acid, enzymes and food from invading the mucosa. It has the effects of reducing pepsin activity, increasing mucin secretion, and promoting the release of prostaglandins from the mucosa, thereby enhancing the defense of the gastric mucosa. In addition, it also has a certain killing effect on Helicobacter pylori and promotes the healing of lesions.